Armenta was established to address the most pressing disease affecting dairy farming today: Bovine Mastitis.

Losses due to bovine mastitis can reach several billion dollars per year. Armenta developed innovative non-invasive; antibiotics free therapies based on acoustic pulse technology (APT). APT has been used for over 20 years in human healthcare treating inflammatory diseases. Armenta employs experts in acoustic pulse treatment and engineering, mastitis researchers, ex-dairy farmers and dairy farming operation, bringing their skills and proficiency into developing the optimal solutions for bovine mastitis.

To that end, the company developed an innovative, non-invasive and antibiotics-free therapy that has proven to increase milk yield and quality, as well as reduce culling, using acoustic pulse technology (APT).

Armenta Ltd. Downloads

Armenta - Model APT-X - Acoustic Pulse Technology (APT) - Brochure